Fenofibrate Tablet
Product Images NDC 0615-8530

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 0615-8530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Fenofibrate Tabs 8530 1)

Image (Fenofibrate Tabs 8530 1)
Chemical structure of fenofibrate, showing its molecular framework including aromatic rings, ester, and carbonyl functional groups as part of the compound's chemical formula.*
FDA Label Image

Principal Display Panel (Fenofibrate Tabs 8530 2)

Principal Display Panel (Fenofibrate Tabs 8530 2)
This label sheet features multiple small labels for Fenofibrate Tablets USP 145 mg, an oral tablet manufactured by NCS HealthCare of KY, LLC dba Vangard Labs. Each label includes the product name, strength, lot number 8530, barcode, and packaging information from Vanguard, Glasgow, KY. Storage instructions and dosage notes are included, specifying controlled room temperature and institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.